Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD)

Cannabidiol (CBD), a nonpsychoactive major component derived from Cannabis sativa, widely used in neurodegenerative diseases, has now been proven to have growth inhibitory effects on many tumor cell lines, including breast tumors. Meanwhile CBD can effectively alleviate cancer-associated pain, anxie...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Jingxin, Zhang, Kunfeng, Lu, Likang, Li, Manzhen, Han, Meihua, Guo, Yifei, Wang, Xiangtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332327/
https://www.ncbi.nlm.nih.gov/pubmed/35893789
http://dx.doi.org/10.3390/pharmaceutics14081533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332327/
https://www.ncbi.nlm.nih.gov/pubmed/35893789
http://dx.doi.org/10.3390/pharmaceutics14081533

Ejemplares similares